$CL

Tsourapas Panagiotis sold $920K of CL (indirect holdings)

Tsourapas Panagiotis (COO, CD, EMEA, APac, Skin) sold 10,000 indirectly-held shares of COLGATE PALMOLIVE CO (CL) at $92.05 ($0.92M total) on 2026-08-24.

Original reporting
SEC EDGAR · Tsourapas Panagiotis
Published Aug 26, 2026, 8:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CL
Neutral
medium confidence
Mentioned
$CL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The disclosed sale is modest relative to total holdings and unlikely to move the stock.

02

Market read

Small insider sell with limited trading relevance.

03

What to watch

COO's remaining stake remains sizable, indicating continued confidence.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑08‑24

Background

Form 4 filing discloses insider transactions; traders monitor for signals.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

COO sold 10,000 shares for $920,477, reducing his stake to 64,901 shares.

Expected impact

Limited short-term impact; price likely unchanged.

Evidence & confidence

Sale amount under $1M and insider remains a large holder; market typically discounts small insider sells.

Market effects

No material effect on consumer staples sector.

U.S. market only; no regional ripple.

Low relevance globally.

Counterpoint

Insider may be diversifying; sell does not imply company weakness.

Key entities

  • Colgate-Palmolive Co.

    Consumer staples manufacturer (ticker CL).

  • Tsourapas Panagiotis

    Chief Operating Officer, CD, EMEA, APac, Skin.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

$CLMedAI 8/10

Colgate-Palmolive reportedly weighs US$1B personal care offload.

Colgate-Palmolive is reportedly considering the sale of select mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, for over $1 billion. The company is working with Goldman Sachs on the potential divestment to focus on higher-margin businesses amid North American competition. Personal care accounted for 17% of its 2025 net sales of $20.38 billion.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.

$CLMedAI 8/10

Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Colgate-Palmolive (NYSE:CL) is exploring the sale of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, potentially generating over $1 billion. The move aims to simplify its portfolio and focus on higher-growth areas like oral care and pet nutrition, amid competitive pressure in North America. The company reported a 4.9% increase in net sales, but organic sales in North America declined 3%. Proceeds could be used for debt reduction, share repurchases, or acquisi